r.J:vnrodrfln.

i'ruFrfuu n::]Jn1io114't: uauu't

Gor riryuoronar:utoudngrunr:uuitrul6uuurJa{r1un1:vrs!fiuuoirYuuruzuuflo1tiu
ar:uli t

orfiudrurorrrunruludo a tornnn:vvr:rvjr6'runlrdrrrriuuor"riuu't fl.fi. bddd

filoonmrlrrruluu:v:rtricy{6or fl.Fr.lodoo uravariruffltufrrrfrr uavl:vnron:vvt:?{atot:ilqt
!odooo
rSol riruuorulurirtoruavltle{rn-rynr:fiuyvuiuusirflur a.riufi od Y,{Q1efl'1nil loddb rirrintru
n ilu n :: lJ n : o.r14'r : Lra v u r 6l o o n rJ : v n r rr o't si otrl d
1

rio ,
hftfi:r:runr:ufittu.Jfiuuuilarvvriuuriri!urrzuufloofiunuud'nunruq{uu!fr'rsr
t
, 3a v - J o 4 a
il:vnrnfi'lurio t" rosrJ:vnrrtdrrinrrunruvn::lln'r:0114'r:ttavu1 uSot riruuqtonar:u5ovd'norunr:
urittujduurrilar:runr:vrvufiuuoiriuuruzuuflooriu
It
aflualiufi ted lr'0u1uu v!.fl. l.eddb
rio t, r::nrn'rroruffltu-Jf,uuurJar:runr:vvtfluueirfuuruoluflolriul, 1 fi6uriou !
, &rr- - u @ qu{ t d o rq I d o u
'i
r.J:ynrnfrL{rj.:rYl urayriloulu:vu'irrnr:fror:rur'Lrifio'irrilurirtorufftturjduuttil4{:'tunr:vtutlJUua'l:1r
!-

ulru{uflaxfun1ill:unrflariuflTnuoular
tl
uravfirfinru*nnrixornud'ntnuvimur.l:snrridtfivrrinrru
ri'tarirfifidrurod'.ruflrrfilu6r uavtrfreirronar:rfirrfirnrilnmlsiru{JuravLil}l'lua}r
rio *
r : : n r r{r r o ruitu ur.J d u u irr.l a r : r u n r : v v tfi a u sr'r iu u r tr l.r ufl q
o flufi uon tufl oa l n
- v . 3 ot
"&,uo
radnrnruvifrLfirirra6'n rnruvinurJ: vnrofi lrl{rir6'rTor uoula}.r
ZXY' ,-Xa, v\
ra''sfr d'r uurifnfl utlumu Ll

l:vnrn ru iud sJ Brvrnu fl.fli. tqrdbo

.uu{aa.
(u'lu?utu aelu'l?ellYr.:fl)

ratrBnr:nruvn::!n1:aru1:uavu1
:luaurduorond'rrildn6rufit{rj:snounr:6utoufftturJduuuuja{:tunt:vrsrfiuueiriuurut{ufloofu
'4-'-''---- t

nr: urfftt uJ f, uu ru{ a t :v duudn -trrtalor va ri ati on (Mav)

nr:nJdtruurjaranrufiarBnarf,ntYcudulerltJUrcnladrrintunruen::iln'l:41il1:
A-t^9elr4a
uasul [:o{ uan[nilfl n1:Y{01:6u'laq[u1nn1:o''l,iHanuas01{?[n:1eils1ur.lu

rttlun,: t. nr:tr]Euutu]aranrufizufrnzu6nfiruciurrr'riltJ:untndr#nlrunruvn:r!n1io'114'ti
Aw a - d a ' yr,iarrrzuuflooliu a u4
uulJoun [t lLAuU1 150{ vAflLnfUflnl:v,lAl:il'lOUry1An15A1{ria9ltLauQ1.1?LF]:1i !

rravuruzuuTr:rru
rujfruuuujar
z. ri'ir{x urrunru'ir
(r.) ry'ilor1ryrmzu6nr,rio{:-rorlryrmrjrraio&rdr:rrtu:rtotruto-n:firuruzuufloqiu
j. v yA o d o u o rtr& d o u
firirrfrunr:'ird'x{6utri'zufirtarfirruovtot-uvvtfloun'rilurvSoldt-uvrvriaurr-r:nar
L,)

u 6 At w v a o , c
(2.) u0rto.lzuannilfl Lun1{!:utvtflv]?'tQ1{Hrian Lu!:uLvtfl Lvtuvtlnl:,.taau1?0.inu

a. {:-ui'rrzu6n (contact manufacturer) urruntrl'jr {zu6mlurJ:vtvrrtvrafi:-ui'r.rorn

qZ,oA,q'o!'vlo
,.J',t1Q',t.tl.t1yl1n15t,Ja0lul
i-
Luu1.1tuFlouv:0ua1utu9l0u ttn LlJS?il0.1tutrl0uafivl1uvlr{an

fr'ornaroliltd
U9
4. lu u qi av r-u n o u n 1 T,,r a rr a v o ulqru 1 rrtfifr f! ir {r t zu fr ntoiufi ar :r u rfi u r rvi r riu

-
r0n61flimo{ 1 . rir ru r y rir f; o d'ry ry r : v ra'j r.r ry':-r 6'r r u a v {'j r 6'r r
4d - v4 - .j .,i
z. ^
uu{ao5!50.1}J1rl:o'tu6fi'tuvttiaFtulnt}.lvtfi'r14uolflurj:vnr6nSvvr:?.1fi'1015il4fl
uu[v'10
,ol

rJ:vnounr:
lu:r u nr :yrr na rfi iu i'r wl fr n

:. do4anr:finu1Fr?1r.rn{anrvr6'o.ru{JuhnrlASEAN Guideline On Stabi[ity Study

v{o''r:6u''l
Of Drug Productttau:'tu{1ulun:dfizuanr:6nurtrjlfluhnr:rdorirrauoilleritluorq
v o a A d.j i
u 1 vr : o l.l rru't vl 1 { n1 : n 1 Lfr u n'l : (Lu n 5 rilfr r fr o r rio.r )

4. to n ar: rir fi! u r ra v aa r nfi r : v I t dr fi ro rurilt ril f; au rl a{ 0u n : fi fi rfi urrio t)

 5. trzu u uta v/u6 o:r ur ru n rr rt:? aao ! n? u o n olo rt orn : v !? u n 1 : r,r fr sr t or an r ufi zu a
to urTlt rl6uuuilarlnu'l#rfl utrjnuRsEAN G uider.i ne on submission of
Manufacturing Process Val.idation Data for Drug Registration (uaurv"frroufi
rfiurrio.r)

o. do4ailialtfiuun:rdtLan{fl1:auarutorzufrnflruo{;rluutoru{trfrnirrJ:rrrudo
!

rufrmornaarufizufinfitri'iro1.{tU1Fr ru flolriuuavfiro*ri'[tur.JduuurJarlrrui6nr:ynraou
d'!,todrad
n1:aualuft'i na1?r1Ju [!n,l}t011:'tut rtavilnr:n:?aao! n?1:Jnnm'oltoli6nlsyaao!
I u a AA v
n1:aualuuuo?u ( Lun:ilvttnurtol)
7. :vuu nr:riruuo:fi'arol{unr:zufr n (Lun: fi fi ifi urdo.r)
a. cio rir u u rur r a i 5'r u 1r o { r-n q n- I d'r u r rir 6'ry (lu n : fi fi r n' a.l do r)

9. nr:uoaolnr:fr nur:u uy L?a1n1:rfi l:"nur (Hol'ding time) torbut k pack lu

:vv?1.in15 Lnuttaun'l51tud.t:u14?'t'iffnruvtzua nnnanruyt=l::Qa{n11Juy!i:Qfiale.iiaur
ri
n oAA u
( LunSruytnu?t0.t)

Non-AVG n1:tv{iln1T overage

MaV-2

ltoutulunr: 1. nr:rfrrnr: overage rorr-nqfiun'rardrd'ryfrortriuflur.iaornnl:vrnaounr:6nrsr

6utoufftr n?r lJ n {aa 1il to.r ar fr n airu*{urrir r5 o :ri

U

z. dorirraurrillFl:51unt:rl:?ala'ouu6orirurfiodrrariruuavdoriruunrrn:oruoluul
rrja^uu$da.:
r o.r zu a' n ri'rudu r 6'o ltri urj a' u u urj a r
Av
[0nd1:V191O.1 1. ronal:uantrunnalunr:rouri'ltu.Jf;uurirJaruioruur:rioqaarirat{, -j, p2, ,t
dd
uu[11r0 niru ur vt I I rn a-t n ::l (Pha rm a ce utica I Deve [o p m e nt)

rJ:vnounr: 2. nr : x uJi u rr rfi u ! an :r or iu nr : ru 6 r r'ti':n o t1 ry r n ru rJ o l uiu ura v fi t o rr fflr

rrJHuuru..Ja.l
vr01:ru1
3. nr:xurJiultfruu batch anatysis torzua'nfiruqi'arfit6'ilourulet ru floolYu rravfi
---
I u i
4,i
rorrf[rurjfrrluuilat o"ruru 2 iu
+. rarirf;oil:otzuanr:irn:ryvirorzufrrrfiruc{ur siruru z iufitourihuJf,auurjal
t
s. rio|a nr:finurnru nranrn 6'ot rfl utrl pruRS rRN G uideli ne on stabit ity study
of Drug ProductLt6v:rutrulun:fifinranr:finrcrtilrflutil0rudorirraunlJ.l0t:s.ruo1u

ur (niolrruryrlnr:rir rfl unr:)

 i
rn :r sr{ua v da dtau o tr n :gr ut o.: in qG u d'r ordr da; l,r€a

Non-AVG

n) nr:uJdaui6irn:T c#uasdoritauoillo:sluorn in-house rflusi,r:rurdiguuorB

MaV-3

t) nr:rddsuurja.rr[adafl edou

rtouhtunr: t. n:fifinr:rrlAoru,.Juofirii#finrruffl*Gorurloo crp l#ul'.,,frrrnru*rihd, Ir,til.

6utorufflr
2. nr:tr.Jf;ourujatfifr'ottritfluzuarrnruqnr:nifitrinro6ofirfrsrdulu:vu.irrnr:o.16nraio
rujHuuuur.Jar
flryurnrrun{6n1nu1
1. ronal:rraorruqzua1unr:rourTltr!f;auurJarniorua-noruvrrtirrnr:rj:vnor
l-a-

2. nr:'xuJiuurfruuliorfruuoillrr:-qrurorr-nnfrrn''rurrirn''ry r,l3ozuamfirudardtti'fli

d:vnounr: oqrulFr ru flo1fu irasfitouffltrliuurirlar firuanrnr:uJialrfiuldonnufitouri'lr

l#tYomu
tior:rur d ada r! t4 ,.j Au
i.^ r0 na1::'t u ay [0 u n?0? tn :rvuvito ttn Lt rla uu rr!ar/ n-r:r arfr o'rl dt
4. r{anr:Frr?aaouFr?'r}JQnfrorro.riBirn:rvd (verification/validation) rravdo4a

rujiuurfiu!zuanr:irn:rvdaBdtri':-uourulrr il flrol-uniriBfitouri'ltuJHuuu!ar
s. rjoriryupuJtrr:o1ufl1:n:rorJdouytr*'.rr,rtrtrrr:.,u,*rJri.,ruru..rrru.tuo1rlu.t

tolzufrnniruc{ar vio{orirvuo}J1rr:6rutorimqGu6'tarrirrirgfirouuitruJf;riu*r]aq

o. doXanr:irn:rvr.i{unr:2fin (aui.h analysis) uorinqfrln-rurrirrYrX raioilamfiruq4'

ar vr nfi'rdo n1:rnao! nluriorirrauqilr n:orufi ro urih uJ6uu urJar druru 2 junr:

ar fr nrjr i o I ra:*o qun r :ar 6 m
...-6,taov
7."[u:"tl:olu.raitn:rvlitow-rurrirn"rylzuanrYrudur(Certificate of anatysis)
1n#rdo
nlivr nao!rtrilrio rirrauqlrsr:orulrail
B. rio4anr:finurnrun.,on'.tri6'r',,flutr.lmu ASEAN Guidel'ine on stabiLity study
of Drug Product uav :ralrulun:nifizuanr:rt'nrgrhjrflutrjntrtiorirrauoil'tn:01uo1u
4t
or (vr io:r uuryrr nr:rir rfr unr:)
 udltuJdauurJar uondr:nauquqrunryrluvrsrtiuusl"riuurt#!fl uhJfl rrJ ncrD

J_dt
outulunr: rru n n1: uu rr1J1J u.5 LLJu 3 rilro rra v 6ul rlun5't? 16 u't n-u
dw
UUUOlrn tfl 1 . to n ar : n1 i Fr'r u Fr I.r
9!au
n il n'r y! ? o { ?-n n rl ! 6'r u r rir 6'ru

urjduuudas 2. to n ff r : nr i Fr't u ni!lJ n ilfl r u dr u nr : zu fr n zu 6 n alcuqi' u r

3. Lo na1:nr:n?!nilFt
tq runrilro{ zu 6 ni'ruci'rlr

Av
r0nd''r:vl9ro.l 1 . to n a'r : n1 : n? ! Fr lJ
tatq
n run't v! t o{ irt nA u m'r u r eir rYru
dd
uuty'I0 ro n ar:fi'?{o S t -Sz nu fifi oydn un ruc{n r :fl uvr v rf, uu m"r:n ur ru! AS EAN (ACTD)
Au,.j
vtlj0Ltn LrLUauuLr!a{
il:vnounr:
2. Lo n a r : n 1 T n? ! n lJ n 6un r
!t
n rir u n r : zu 6 m zu fi m airuc4u r
1,!01:il1
rona'r:u'?do P1-P3 nrlnifioya-nrnru"finr:duvrvru^auc;r'rilarrrt! ASEAN (ACTD)
fitouritruJduuula{
3. ro nff 1:fl 'r: n?! nil
!t
n ilnrnro.r nfr nniruviar

ro n a1 :fi'? do P4-P8 rr u rifi oydn rn ruc{n r :duvw rfl uu ar"r:n or ul! AS EAN (ACTD)
A * ,-.i
llljOLrn LTTUAUUTTUA{
 n r: rrri'tt nJ d g u utJ ar :v rr'u r0.r-M i no r Va ri ati on (M i V)

Non-AVG vriel r n r u il : v n 1 6 d1fin { 1u n 6uu n ::u n 1 :o 114 1 : ua uu 1 i

udnrnnreinr:fior:anaqryrrrnr:drrru6nuav{rrirn:rcfuruaruflonriuuasulurlu
MiV-PA1

outslu 1. nr:rfiranrufiirn:rvv{ur0}r}.rl:vnrndrfinrrunruunr5}Jn1:o'rur:utavar tio.r

d ua'n rnruryinr:rfror:ruroururmnr:6'xzu6n riav{rti rn:rvdurttr'ruflorriuttavur ttruu
n1:uulJ0 !u !

L!:1fU
ruffls
z. fi'ir{'rr vrranru'ir
rrjHuurrrJa.r
(r.) ri'iuor4yrmzufinraio{iuorSyrnrjrr,rioartudurlurltolru''}Q-fl:d.:uruzuuflo1liu
! v vA c 3 d o u a vtv& d
"
?rq'r ruunl:'rrox arou
U
t#i rn:rvdurfi nuQu?orJuvru rll uue)'r:u u'rra:old'f,uvrv rf, uu
vv
F]I:1JU'I L?

(2. ) 16'r r or zu fr m rirucflLu ri trJ : v lvr r fi 'j li'r r {2 6 nluil : u tvr fi tv u ra6 o rlo r rJ fl ri6 nr :
n? u nil n run r:i tn :r vviort o t mu
1 ulurj : v ivr ntv ulir n

a. ry'ir{'rrirn:rvv{(contact [aboratory) ulrunru'jr ry'zufrnraio{frn'ri'o.rr]frrifrnr:

n'r!nl.rniln1nlurJ:v
!tv
rvrntvrufi:-r{rtornri'iri'xlrdrnr:i tn:rvr,iurlurrrra'rdoraio

+. {ir 6'r ri r n : r v vlo s fi o r fi ri'o uJ fl l-fr n1 : n? u q }r q il n r r fi fi q ru a :r 116 ni iI

-i ^ - - Auv- q
( t ) rfl u#o r ri fr ffi n r : nr r r q lr q il n l v! lr o r a n r ufi zu a m u r u zu ufl n 1rtiu fi tri:-lh o rl ry r m

uavrirunr:m:roil:vm-unr:rlflrifimruua'ninruqiuavi6nr:'[unr:zufinur (GMP) turiru

ddv4
iltnu?to{ v:0
(z) rfluri'0.:tifrtGnr:nrrqlrqrunlv,,rlrornrnrigratorontu fitfiirlrrniilufllrr
lso/l EC : 17 025 v6orrm:oru6ufi rfi uurvir
s. fi doranr:rir
v11
uvo o ivnirlodn'.lr.runlJ nrufl 'n\ (method transfer) fi n:lfiru
J
[0nd1:vt t . dr rur v rir f, o #ry ry r : v r,r'j r r
{ir {'r.r *a v {'j li'r.r
vAd z. raa'ngruuanvirrflufiortJfl^rifinr:o?!qlrqiln1v,iroranrufizufrnuruzuufloq.rnfi
a0{uulvr0
ld:nhoururnuavnirunr:m:rorJ:vrfrunr:rJiri6nuua'nrnruq{uaviBnr:lunr:zufrnur
rJ:vnounr: 10 d
v4;
(GMP) turirufirfiurdor vio r{Juri'otrJfrr.r-finr:n'run}.rnilflrv,{?o.imn:Eu:oronru vl
v{o't:ru1
t6'iunr n:oru
44
rrrl I SO/l E C : 17 025 u6ol r n:o'ru6ufi rfi al rvir
ytsld
:. riola
u!t
nr:ril uvr oo trn Lu La unr:n?unlJ n rualv! (method tra nsfer) fr n:uriru
 tvadAaadd
4.:ruavrdtJprTSlun:rvu LLavtianl:rt:?aaoun?'llJqnn0.i?0.i?511Fl51u14 (Lun:ruvl
rfiarriot)
5. uo nar: rir nfu ur uavaarnd.r:vufi! Ifi to urfftt rtlf; ou utrjaI 0u n:fi fi ufi urdoI )

iau
Non-AVG nl5Lv{iltu9t?i
I
.d
rJ:1f,o1nrt0
MiV- PA2

fioultlu t . do rir y u n tr 1 n :5'r u n 1 : n :r o l a' o u ui o ri r u rfi o El'r rari r u tta v do rir vu n l r n :St u o 1 u u 1
d rol zufr nfiruviur (end-of-shel.f-l.ife specifi cations) 6'olhjfi nr: rrrl1t ur]fi uuttrjal
n1:uulJo
2. n:ninr:iuittril6uurlalriaou::oniruc{fie'r2-aur
tt
to.rr',rfrnniruci'u1ilrrfla'tnttfo lrfr
rufftt
av
air rilunr:nuvrto MaV-1 2
ruJf,suur.Jar

Av
tOndl:Y40.1 1 . ro n d'r : LL ao l tu q zu atu n r : rr,l' l ia qu : : l ntud rra v zu an r : fi n ur n u v a-n i t r n r :
dd tY}J'IUfi}J
uurv{0
Z.;irraiuzu6mflruc4Ur:illLU!
'-_- semi-so[id *avto.ltraarfrotduva-nErurrant'jrtrifi
il:cnounr: - !

rJflfr3ur:vra'jrrzufrmriruviuruavriaqt::nnlcuvi (uriu hjfinr:r.Juuflouto.ldru!:vnou

V'lO1:tU1
ra{iaq!::oriruvfluzu6mriruryiur
-----'i---i--'- - ravlilfinr:arurf,urilur.J:vnoutolzufrmriruc{urudr
uu

ttlluu::1firud)
3. rrr:rrurjiulufiourjoriluuflillrriorutolriaqu::ErYruc4fia-l.Jfiauriitri:-loUfulrr
ts ru
-,"-;-"-."" t---i'-'
i q ,:
rl ooriuuravfr to urn'lu u,.Jd uu ur.Jal(Lun:nifr rfr ardor)

q. ,rnu'.rr,i'.rnluorutasaarnd.r:rld.:fitorrri'ltrrjFuuur..Jal([un:fifiufiurdol)

s. {ola nr:fi nur nr}.t nounlr 6'ro,ttuhj nuRSEnN G uide l.i ne on Stability Study
Of Drug ProductLrfiy:rulrulun:fifir,ranr:finrgrlrirflutlnrrriorirvuoilln:5'luo'lq
or (r,r iol utu'rvrq nr:rir tfi unr:)
6. ronali P7 nrlrin'oua-ninruvinr:duvrrrfluun'riluruuu ASEAN (ACTD) fito
rurilturjfiuuurjar
 t. {oriryuruJrrr:6runrin:'lorjrioara6or.irurfiorirrariruuuav"lioriruunlrn:o'lu d

An aul
uuljoun [t OlqUlrO{,.,J4nflilflu't (end-of-shel.f-life specifications) 6'olhifinr:rrrilt
.;
rujduuuda.l LUAUULL!A.I

1 . ro n a 1 5 rra o { 114 flitl,r alu n 1 : tfr il {A q ! : : 1 firuvi tt a v zu anr :

rfiorJ:snounr: !14l.J1u41.1

2. ro nar:rir n1l ur ua vaar ndl:vqdIfi to rrfflt rrJ6 auttila{ 0un:fi fi ufi urdoI)
fior:rur
l. doqanr:6nu1a?lllFt{an1v!1Jo{r,lArrriruq{ur:vy'jrlldtru (ln-use stability) 6'ol

rfluhjnr:r ASEAN Guideline On Stabil.ity Study Of Drug Productttau:'lU{lulu

n:nifizuanr:finr*rkirfluhJnr:rriorirrauol.Jln:5'luolqul (vliotttturvrtnr:
rirrfiunr:)
4. ronal: e Z nrl{fior,ld'nrnruryinr:duvryrfiauoirilurrlu ASEAN (ACTD) fito
* ..j , a oi! v \
ttn Lr L!auutL!a.i ( Lun5ilv! tnu?10{)
 t. yrirf,oir:o{ CEP nfortonar:u' oonlfru European Directorate
J for the Quatity of medicines (EDQM)
[Y'lOU:Un0Un1:
z. {o rir vu n }r 1 or :o1 u1r o'1 ?-n q A ! n-'r u'r rir 6'ry 0u n : nifi rfr u r dor )

3.:'ru.i'rurianr:itnr:rvviiunr:zu6nornfizufim'r-no6!er-lu1d1flil*
tstu firrflutrimtr
P h. E ur Monograph :rl firi6nr:vnao! tfr ! tAl uav tnruryinr: aoI:-lfi :vqtf[u
vrirf, o:-r:or c EP (Lun:nifi ufi arrior)
v - - f, .j j s .jr, o
+. doXa ui'l 161 6u 1fi rfi urdorfirtil:vrluvri.:f; o:-u:o{ cE P rdu doqanrrlnr
fin'rv! (s7), drt:vsvrrnrlirnr:vnaou"u*ruurq*a:rrl6ri'rhvnrunfi/nrunrn6ul
(tduri tur oroqn 1n (pol.ymorp hlsm) rfl ufru flu n:fi fi rfi urdo.:)
;rJur4a-rugru
s. fir nr : ruTh u.J d u u ruj a r r fi u r rio r ri'urio rir uu o r r Fr : onr u t o { ?-n n 6 rL or-r u r rir druu" lfi
'
d' - a vu ; o o - !
"
uuuu{a0x'tnzu:!ourultrl:!:0.1?1xv!:}Jv1n1:flnu1F]?1}.Jn.:afl1TtlJo{r.laFlfltuYlulvl
u lq

tRu?to{F1lr the ASEAN Guidetine On Stability Study of Drug Product LLauQv

rir rfr u n r : 6n ul n ?'uJ Fr { fi n r n dr ndr r o u rrdr ra S o ua v : r a r ulu n : fi fi zu anr : fi nrcr

hi rfl uhJ nr l rio rir vu o r r a :81 u o 1qu r (u io l uur vr r t n r : r{r rfi u n r : )

*firr'izu6nr-nnfrun-rurrirdrun'urirf,o:-r:o.r cEP uave'iei6nzufrnniruq{urdx6.r

UIOU

dorirvuor r n:otutor':-nq6u O'r urrirriry6u ( utiu U SP, J P, I n-house rfl udu)

rizufr rr zufr n
!U d'ruviu r o v 6'or duriol ado 54. 1 fi { 54. 5
 nr:uffhuJduuudauonar:rirriuurtrin:.rflruronar:rirrYuurvrttriiuoqrylnoln

drrinq ru n ru v n::il n1: o1 14 1 i ua vu 1

Auy_ y a X
rtttunr: 1. ro n al:n1 n! ulvt lo:1J0u! n 01nalun{''lun 6uu n::! n1:0114'15 ltau ul Fl0.iil tuo141
d,\,vod4dl
Jq
uuljoun tfl rlju LU Fl',tlJ10 n1uuo01 t{ uu 14:0 tvl u1j tvll
z. rflunr:rui'lrur.Jduurula.:fif;urflo.rlra']nn1:tileuutda{Lona1:rirfiiurtotar
rujdtruurilar
v,
fiutiuu (origina[ drugs)
3. n:fironar:rirfiuorro.r{zufinlurJ:vtvrfi (vrvtf,uuzu6nviour-jr!:rnu16'utt1JlJ
(original. drugs) raion:firy'rira''rr firfluvrvrCuuer'rr-uurfifido4arrafiousir:nurfitdil
! a A qv v q
f,uvrvrflauliudr'Luf,onr:rirlvri to{urfrurlu (originaI drugs) rirvunrl#tonar:
YA
n r n u u'r Fr o.r r1iil o u n ull n | 5un1 : un t{ufi onr : firlrailtu vr v tfi u u u r

1 . a a 1 n rra u ro n a r : rir rYu u r arir fi t6':-r o ututu'r Ft ru rJ t o

i
liu
JJ 2. aa1n tta v ro n a 1 : ril nl1l u r fi t o ff1t uJ 6 u u ini a I
uu[v'l0 ur

3. ro n a1 : uta a { ru r] r,r alunl i? o rLfi'[r rl 6u u utl ar

rJ:vnounr: I

4. ronar:rirfi!ur (Package insert) doqaalJtolzu6nfiruc{mr:JLL!I..J Summary of

v{Q15[U1
Product Characteristtcs (SmPC) u6oronar:rirnluurdrvir{thu fiLil:-loqtu'lnto.i
dou
yrvrtousiriuurduuur (original.) rravdrrurrirtoiui'hui6uuru.Ja'rfi16'ilo1.{ry1rrx1n

drrinrrunruv nr:! nlio'r1i1: lrau u'r

s. vrir f; o 0 u u o l.r a 1 n ri"rr o': zu fr n rYrucfll#dr r 6 t ro nar : rir riu u r

14lJ''ru[14sr n:finr:eir:ru{lurJanlrai?aaoun?r}Jnn6'ottorn:vurunr:26n (Process val.idation

t!
report) r,ld'.rornkiiuhrirrYrynr:rsuvrrru^uuuru#r trid'qr{Ju nr:uritturJf;uuutla.i:1unr:vvuiuum"r:-uur
trin'ruflunr:lirrari.rf;ofi.rrirrinur rvl'orir:rurrurianl:n:?aaounrunn6'o.rllo.iniu!?unr:26n (Process
Val'idation report)